GenScript Biotech introduces FLASH Gene sequence-to-plasmid service

GenScript Biotech Corporation, a leader in synthetic biology and gene synthesis, has introduced its latest innovation: the FLASH Gene service. This ultra-fast sequence-to-plasmid (S2P) service is designed to meet the urgent demand for high-speed, high-quality, and cost-effective gene constructs. With an incredibly swift delivery time of just four business days, the FLASH Gene service sets a new industry standard, priced starting at $89.

The FLASH Gene service encompasses gene synthesis, cloning, and plasmid preparation under a flat-rate pricing model. This service is not just rapid; it guarantees plasmid yield and 100% sequence accuracy, thereby empowering researchers to accelerate their projects in areas like antibody drugs, vaccines, and gene and cell therapies without compromising quality.

GenScript has scaled up its operations with an expanded facility in Piscataway, New Jersey, extending the FLASH Gene service worldwide. This expansion ensures that regardless of location, customers receive the same competitive pricing and speedy service.

The introduction of the FLASH Gene service by GenScript is a significant advancement for the scientific community. Offering such speed and precision at a cost-effective rate is crucial for rapid testing and development in biotechnology. GenScript’s continuous improvement based on customer feedback highlights its commitment to not only meeting but exceeding the needs of researchers globally.

Dr. Ray Chen, President of the Life Science Group at GenScript, emphasized the importance of the FLASH Gene service in addressing current market challenges and enhancing research capabilities. “Our dedication to innovation and our customers’ success drives our efforts to offer the fastest and most reliable gene synthesis solutions,” said Dr. Chen.